Freemelt (FREEM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Feb, 2026Executive summary
Achieved record net sales of SEK 54.5 million in 2025, up 172% year-over-year, with Q4 revenue of SEK 15.6 million, a 91% increase from last year.
Installed machine base increased by 40% to 40 units, with significant expansion in medtech, energy, and defense sectors; started 12 new paid customer projects and ended the year with nine active projects.
Outsourced production to Scanfil as of October 2025, enabling scalable supply chain and reduced capital needs.
Entered strategic partnerships in China (Jiuli), Korea, and Nordic fusion (Novatron), strengthening market position in high-growth sectors.
Order intake for 2025 reached SEK 60.1 million, with 12 machine and 12 project orders.
Financial highlights
Q4 order book at SEK 11.5 million, down 7% year-over-year; order intake in Q4 was less than SEK 1 million, following strong Q2 and Q3.
Full-year net sales reached an all-time high of SEK 54.5 million, up from SEK 37 million in 2022; Q4 net sales of SEK 15.6 million, with 82% from machine sales, 10% aftermarket, and 8% projects.
Operating result for 2025 was SEK -91.98 million; Q4 operating result was SEK -26.01 million.
Operating cash flow for Q4 was SEK -6.9 million, a 23% improvement year-over-year; cash at bank at year-end was SEK 32.1 million.
Inventory sold to Scanfil for SEK 4.6 million, booked under other income and expenses without margin.
Outlook and guidance
Entering 2026 with a mature pipeline, strong industrial relationships, and a supply chain ready for serial production.
Market for metal additive manufacturing (AM) expected to grow over 18% annually, reaching EUR 15 billion by 2032.
Focus remains on transitioning from academic to industrial applications, targeting serial production in medtech, energy, and defense.
Latest events from Freemelt
- First industrial eMELT sale, OEM order, and machine sales growth amid ongoing losses.FREEM
Q3 20248 Jul 2026 - Q2 saw high activity, new orders, and strategic partnerships despite a wider loss.FREEM
Q2 20248 Jul 2026 - Record sales, fusion breakthroughs, and China entry drive growth in AM and medtech.FREEM
Investor Update1 Jul 2026 - Scaling up with 162% revenue growth, new funding, and global expansion in MedTech, defense, and fusion.FREEM
Investor update2 Jun 2026 - Q1 net sales rose 116% YoY, with strong margins and key sector collaborations advancing.FREEM
Q1 20265 May 2026 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days11 Jan 2026 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 202423 Dec 2025 - Record Q2 sales and global expansion drive strong growth and order intake.FREEM
Q2 202523 Nov 2025 - Record order book and SEK 90M rights issue drive growth in defense, energy, and MedTech.FREEM
Q1 202521 Nov 2025